Menu

Experience

David Burns

    • Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion 


    • Gopuff More Than Doubles Valuation in Five Months With $1.15 Billion Funding Round 


    • Horizon Therapeutics to Acquire Viela Bio 


    • VelosBio Agrees to Sell to Merck for $2.75 Billion 


    • goPuff Hits $3.9 Billion Valuation With Latest Funding Round 


    • Vir Biotechnology - $143 Million IPO 


    • Uber Closes SoftBank Investment 


    • Patheon Prevails in Antitrust Battle with Procaps 


    • NetScout Receives DOJ Clearance After Second Request in $2.6 Billion Acquisition 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Auspex Pharma Acquired by Teva for $3.5 Billion 


    • Antitrust Team Clears Tesoro for $1.175 Billion Acquisition 


    • Appellate Court Affirms Victory for Patheon in Antitrust Suit with Procaps 


Contact us

Back to top

© 2021 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.